Form 4: GoodRx Holdings Executive Scott Wagner Reports Stock Transactions

Scott Wagner, Interim CEO of GoodRx Holdings, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Summary

• On September 8, 2024, Scott Wagner, Interim CEO of GoodRx Holdings, engaged in transactions involving Class A Common Stock and Restricted Stock Units.
• Wagner acquired 70,592 shares of Class A Common Stock through the vesting of Restricted Stock Units.
• He also disposed of 35,777 shares of Class A Common Stock to cover tax obligations at a price of $7.71 per share.
• Following these transactions, Wagner directly owns 184,664 shares of Class A Common Stock and indirectly owns 182,900 shares through the Wagner Family Trust.
• He also directly owns 211,774 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive, with neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key executives and their potential impact on the company's stock.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a key executive.

Key Dates